HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip J Gold Selected Research

Philip J Gold Research Topics

Disease

9Neoplasms (Cancer)
11/2023 - 10/2009
4Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 09/2006
4Adenocarcinoma
01/2023 - 09/2010
2Colonic Neoplasms (Colon Cancer)
10/2022 - 01/2019
2Cholangiocarcinoma
08/2012 - 12/2011
2Esophageal Neoplasms (Esophageal Cancer)
05/2012 - 09/2010
1Breast Neoplasms (Breast Cancer)
02/2024
1Microsatellite Instability
10/2022
1Peripheral Nervous System Diseases (PNS Diseases)
10/2022
1Turcot syndrome
10/2022
1Hepatocellular Carcinoma (Hepatoma)
02/2013
1Venous Thromboembolism
08/2012
1Carcinoma (Carcinomatosis)
08/2012
1Diarrhea
02/2012
1Anorexia
02/2012
1Exanthema (Rash)
02/2012
1Fatigue
02/2012
1Nausea
02/2012
1Vomiting
02/2012
1Gallbladder Neoplasms (Gallbladder Cancer)
12/2011
1Pathologic Complete Response
12/2011
1Heart Diseases (Heart Disease)
10/2009

Drug/Important Bio-Agent (IBA)

3pembrolizumabIBA
11/2023 - 01/2020
3Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2022 - 12/2011
3Capecitabine (Xeloda)FDA Link
10/2022 - 09/2006
2Trastuzumab (Herceptin)FDA Link
01/2023 - 01/2020
2margetuximabIBA
01/2023 - 01/2020
2Tyrosine Kinase InhibitorsIBA
10/2022 - 02/2012
2Fluorouracil (Carac)FDA LinkGeneric
10/2022 - 12/2011
2Irinotecan (Camptosar)FDA LinkGeneric
05/2012 - 09/2006
2Cetuximab (Erbitux)FDA Link
05/2012 - 09/2010
1Sunitinib (Sutent)FDA Link
02/2024
1NivolumabIBA
09/2023
1IpilimumabIBA
09/2023
1Circulating Tumor DNAIBA
01/2023
1Biomarkers (Surrogate Marker)IBA
01/2023
1regorafenibIBA
10/2022
1cabozantinibIBA
10/2022
1Leucovorin (Folinic Acid)FDA Link
10/2022
1Monoclonal AntibodiesIBA
01/2020
1codrituzumabIBA
02/2013
1GlypicansIBA
02/2013
1Alkaline PhosphataseIBA
08/2012
1BilirubinIBA
08/2012
1Sorafenib (BAY 43-9006)FDA Link
08/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012
1Cisplatin (Platino)FDA LinkGeneric
05/2012
1Adenosine Triphosphate (ATP)IBA
02/2012
1Phosphotransferases (Kinase)IBA
02/2012
1bosutinibIBA
02/2012
1GemcitabineFDA Link
12/2011
1Messenger RNA (mRNA)IBA
12/2011
1ErbB Receptors (EGF Receptor)IBA
09/2010
1romidepsin (FK228)FDA Link
10/2009
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
09/2006
1Thymidylate SynthaseIBA
09/2006
1Thymidine PhosphorylaseIBA
09/2006

Therapy/Procedure

7Therapeutics
01/2023 - 09/2006
4Drug Therapy (Chemotherapy)
10/2022 - 10/2009
2Adjuvant Chemotherapy
10/2022 - 01/2019
2Radiotherapy
05/2012 - 12/2011
1Duration of Therapy
01/2019
1Neoadjuvant Therapy
12/2011